Volume 20, Issue 11, Pages (September 2017)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 22, Issue 4, Pages e4 (October 2017)
Volume 28, Issue 2, Pages (February 2008)
Molecular Therapy - Methods & Clinical Development
Volume 29, Issue 3, Pages (September 2008)
Volume 44, Issue 1, Pages (January 2016)
Volume 42, Issue 3, Pages (March 2015)
Dissolving Microneedle Delivery of Nanoparticle-Encapsulated Antigen Elicits Efficient Cross-Priming and Th1 Immune Responses by Murine Langerhans Cells 
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
Lung Natural Helper Cells Are a Critical Source of Th2 Cell-Type Cytokines in Protease Allergen-Induced Airway Inflammation  Timotheus Y.F. Halim, Ramona H.
Volume 13, Issue 6, Pages (November 2015)
Volume 40, Issue 2, Pages (February 2014)
Skin-Resident Effector Memory CD8+CD28– T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis  Gang Li, Adriana T. Larregina, Robyn.
Preventing Allograft Rejection by Targeting Immune Metabolism
Volume 26, Issue 3, Pages e5 (September 2017)
Volume 21, Issue 3, Pages (October 2017)
Volume 40, Issue 3, Pages (March 2014)
Volume 31, Issue 2, Pages (August 2009)
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Volume 28, Issue 4, Pages (October 2015)
Volume 24, Issue 8, Pages (August 2018)
Volume 34, Issue 6, Pages (June 2011)
Linda Balabanian, Christopher L. Berger, Adam G. Hendricks 
Volume 44, Issue 3, Pages (March 2016)
Volume 38, Issue 3, Pages (March 2013)
Volume 25, Issue 3, Pages (September 2006)
Co-stimulated/Tc2 cells abrogate murine marrow graft rejection
Volume 34, Issue 5, Pages (May 2011)
Volume 43, Issue 6, Pages (December 2015)
Volume 11, Issue 9, Pages (June 2015)
Volume 22, Issue 4, Pages (January 2018)
Volume 44, Issue 3, Pages (March 2016)
Volume 28, Issue 6, Pages (June 2008)
Volume 13, Issue 12, Pages (December 2015)
Volume 48, Issue 4, Pages e4 (April 2018)
Volume 2, Issue 1, Pages (July 2012)
Volume 29, Issue 6, Pages (December 2008)
Shelley Gorman, Melinda A. Judge, Prue H. Hart 
Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node  Lifang Cheng,
Katelyn T. Byrne, Robert H. Vonderheide  Cell Reports 
Volume 33, Issue 3, Pages (September 2010)
Volume 34, Issue 3, Pages (March 2011)
Volume 19, Issue 1, Pages (April 2017)
Volume 29, Issue 6, Pages (December 2008)
CD301b+ Dermal Dendritic Cells Drive T Helper 2 Cell-Mediated Immunity
The Strength of T Cell Receptor Signal Controls the Polarization of Cytotoxic Machinery to the Immunological Synapse  Misty R. Jenkins, Andy Tsun, Jane.
Volume 11, Issue 9, Pages (June 2015)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 39, Issue 1, Pages (July 2013)
Volume 25, Issue 1, Pages (January 2017)
Volume 7, Issue 3, Pages (September 2016)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin  Rajesh.
Volume 15, Issue 1, Pages 9-18 (April 2016)
Nathalie Schmitt, Yang Liu, Salah-Eddine Bentebibel, Hideki Ueno 
Volume 29, Issue 6, Pages (June 2016)
Volume 33, Issue 4, Pages (October 2010)
Volume 14, Issue 3, Pages (September 2013)
Human Langerhans Cells Are More Efficient Than CD14−CD1c+ Dermal Dendritic Cells at Priming Naive CD4+ T Cells  Laetitia Furio, Isabelle Briotet, Alexandra.
Katelyn T. Byrne, Robert H. Vonderheide  Cell Reports 
Volume 15, Issue 11, Pages (June 2016)
Volume 19, Issue 1, Pages (April 2017)
Volume 28, Issue 5, Pages (May 2008)
Volume 17, Issue 5, Pages (May 2009)
Volume 38, Issue 2, Pages (February 2013)
Volume 13, Issue 6, Pages (November 2015)
Molecular Therapy - Oncolytics
Volume 25, Issue 1, Pages (July 2006)
Hypoxic Ag-specific CD8+ T cells are less functional and less proliferative. Hypoxic Ag-specific CD8+ T cells are less functional and less proliferative.
The effect of βAR signaling on the generation of a cytotoxic CD8+ T-cell response in vivo. The effect of βAR signaling on the generation of a cytotoxic.
Presentation transcript:

Volume 20, Issue 11, Pages 2547-2555 (September 2017) Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function  Yael Gropper, Tali Feferman, Tali Shalit, Tomer-Meir Salame, Ziv Porat, Guy Shakhar  Cell Reports  Volume 20, Issue 11, Pages 2547-2555 (September 2017) DOI: 10.1016/j.celrep.2017.08.071 Copyright © 2017 Elsevier Inc. Terms and Conditions

Cell Reports 2017 20, 2547-2555DOI: (10.1016/j.celrep.2017.08.071) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 CD8 T Cells Survive and Mature Well under Hypoxic Conditions (A–D) Flow cytometry was used to analyze the fate of CD8 T cells cultured under hypoxic (1% O2) or normoxic (20% O2) conditions. (A) CD8 T cell death in culture was analyzed based on DAPI staining. Hypoxic cells survived at least as well as normoxic ones. (B) CD8 T cell proliferation in culture was analyzed based on CFSE dilution. Normoxic cells started to proliferate earlier and, by day 2, underwent an extra proliferation cycle. (C) Analysis of cell size after 5 days in culture revealed that hypoxic CTLs are bigger than the normoxic ones. (D) The percentage of mature CTLs (CD44hiCD62Llo) increased in the first 4 days of culture, but a higher proportion of hypoxic CTLs exhibited a mature phenotype. Data are representative of two experiments. See also Figures S1 and S2 and Table S1. Cell Reports 2017 20, 2547-2555DOI: (10.1016/j.celrep.2017.08.071) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Hypoxic CTLs Package More Granzyme-B in Lytic Granules and Are More Cytotoxic (A–E) Flow cytometry analysis (A) and imaging flow cytometry analysis (B–E) of intracellular granzyme-B content in hypoxic and normoxic CTLs that had been cultured for 5 days. (B) The bright detail intensity (intensity of bright spots) of granzyme-B. (C) Sample images of granzyme-B staining in normoxic and hypoxic CTLs. (D) Percentage of cells that contain different numbers of LysoTracker+ granules in hypoxic and normoxic CTLs. Both CTL populations contain similar numbers of granules per cell (two-way ANOVA, p = 0.08). (E) The mean intensity of granzyme-B per granule in both cell types (t test, p < 0.0001). Bars denote ± SEM. (A–E) Hypoxic cells have granules richer in granzyme-B. (F) Mass cytometry (CyTOF) analysis of intracellular perforin content in the hypoxic and normoxic CTLs showing similar expression. (G) Flow cytometry analysis of anti-LAMP-1 in CTLs that were cultured for 2.5 hr with or without B16-OVA target cells, in the presence or absence of phorbol 12-myristate 13-acetate (PMA) and ionomycin. The CTL secretory capacity was similar. (H) Following culture, both CTL populations were placed with B16-OVA target cells for 2.5 hr at different O2 tensions. Hypoxic CTLs killed target cells in vitro better than did the normoxic ones. The results shown are representative of three independent experiments. See also Figure S3. Cell Reports 2017 20, 2547-2555DOI: (10.1016/j.celrep.2017.08.071) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 3 Hypoxic and Normoxic CTLs Slow Down as They Move Away from Blood Vessels and Similarly Distribute Inside Tumors (A–C) Mice were inoculated with a B16-OVA-tdTomato tumor, co-treated 7 days later with CFP-tagged normoxic and GFP-tagged hypoxic OT-I CTLs, and imaged intravitally 2 days later. (A) A frame from intravital 2-photon movie (Movie S1) shows the position of the three cell populations in relation to blood vessels. (B) Intratumoral motility was examined in relation to blood vessels. Arrows represent cell trajectories of hypoxic and normoxic CTLs, color-coded by track velocity. (C) The track velocity of CTLs was inversely related to their mean distance from the nearest blood vessel (r = 0.60, p < 0.0001), but ANCOVA indicated that there was no difference in the overall velocities (p = 0.38) or dependency on distance (p = 0.74) between the two CTL populations. (D–F) Mice were inoculated with a B16-OVA tumor and co-treated 7 days later with CD45.1+ normoxic (red) and GFP-tagged hypoxic (green) OT-I CTLs. Tumors were harvested and sectioned two or 5 days later, CTL positions were analyzed in relation to CD31+ endothelium (white). (D) Immuno-histochemical sections. CTLs populated the tumor by 2 days and further accumulated by 5 days (t test, p < 0.001, n = 6). Although more cells accumulated in the periphery of the tumors on day 5 (ratio of cells in the core versus the periphery 1.14 ± 0.13 on day 2 and 0.30 ± 0.04 on day 5, p < 0.001) normoxic and hypoxic CTLs distributed similarly in the tumors (0.79 ± 0.26 versus 0.64 ± 0.12; paired t test, p = 0.36). (E) The percentage of cells at different distances from the nearest blood vessel in the corresponding images in (D) (Two-way ANOVA, p > 0.9). (F) The average distance of CTLs from nearest blood vessel (two-way ANOVA, p = 0.57, n = 6). Bars denote ± SEM. CTL populations distributed similarly in relation to the blood vessels. See also Movie S1. Cell Reports 2017 20, 2547-2555DOI: (10.1016/j.celrep.2017.08.071) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 4 Hypoxic CTLs More Efficiently Reject Tumors and Prolong Mice Survival (A) Mice were implanted with B16-OVA tumors and treated 7 days later with no CTLs, normoxic CTLs, or hypoxic CTLs. Two-way repeated-measures ANOVA, p < 0.0001, n = 56. (B) Survival curves of the three treatment groups shown in (A) (log rank, p < 0.001). Bars denote ± SEM. The results indicate that hypoxic CTLs reject the tumors more efficiently than do normoxic ones and prolong the survival of mice. Cell Reports 2017 20, 2547-2555DOI: (10.1016/j.celrep.2017.08.071) Copyright © 2017 Elsevier Inc. Terms and Conditions